Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
EVT-801 by Kazia Therapeutics for Ovarian Cancer: Likelihood of Approval
EVT-801 is under clinical development by Kazia Therapeutics and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase...
Data Insights
EVT-801 by Kazia Therapeutics for Pancreatic Cancer: Likelihood of Approval
EVT-801 is under clinical development by Kazia Therapeutics and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase...